APEX BIOMEDICAL COMPANY, LLC

Address

13568 SE 97TH AVE SUITE 202
CLACKAMAS, OR, 97015-6668

Information

DUNS: 831184044
# of Employees: 5

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury

    Amount: $617,779.00

    Traumatic brain injury TBI is an acquired neurological disorder that can cause long lasting disability with limited treatment options Therefore preventative strategies must be emphasized in high ...

    SBIRPhase II2016Department of Health and Human Services
  2. Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury

    Amount: $723,863.00

    DESCRIPTION provided by applicant Traumatic brain injury TBI is an acquired neurological disorder that can cause long lasting disability with limited treatment options Therefore preventative ...

    STTRPhase II2014Department of Health and Human Services National Institutes of Health
  3. Advanced Plate Osteosynthesis Technology to Promote Healing of Bone Fractures

    Amount: $148,448.00

    DESCRIPTION (provided by applicant): Each year, over 6 million fractures are treated in the United States at a cost in excess of 13 billion. Between 5-8% of these fractures experience complications, ...

    STTRPhase I2012Department of Health and Human Services
  4. A Cost-effective Bioreactor to Advance Functional Tissue Engineering of Cartilage

    Amount: $595,571.00

    DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the leading cause of chronic disability in the United States. A clinical goal in the treatment and prevention of OA is to develo replacemen ...

    STTRPhase II2012Department of Health and Human Services
  5. Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury

    Amount: $144,932.00

    DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is an acquired neurological disorder that can cause long-lasting disability with limited treatment options. Therefore preventative ...

    STTRPhase I2011Department of Health and Human Services
  6. A cost-effective bioreactor to advance functional tissue engineering of cartilage

    Amount: $100,175.00

    DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the leading cause of chronic disability in the United States. A clinical goal in the treatment and prevention of OA is to develop replacemen ...

    STTRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government